Researchers working on a trial for new stem cell therapy are aiming to revitalize damaged heart tissue of heart failure patients—while saving time and money.
Scientists are researching how to take stem cells from the patient’s blood to repair damage to the heart. The new therapy could reduce the need for operations, the U.K.’s Express newspaper reports. Researchers estimate the therapy could save lives while being cost effective for the National Health Service (NHS).
Additionally, the new therapy could decrease the time it takes between the occurrence of a major heart attack and the introduction of the stem cell-improved organ to as little as a few months.
To read the story, click the link below.
As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.